Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies

被引:50
作者
French, Jena D. [1 ,2 ]
机构
[1] Univ Colorado Denver, Dept Med, Div Endocrinol Metab & Diabet, Denver, CO 80204 USA
[2] Univ Colorado Denver, Ctr Canc, Aurora, CO USA
关键词
TUMOR-ASSOCIATED MACROPHAGES; T-CELL RECOGNITION; ASSOCIATION GUIDELINES; ANTIGEN PRESENTATION; SERUM THYROGLOBULIN; PREDICTS RESPONSE; SUPPRESSOR-CELLS; NEXT-GENERATION; IMMUNE-RESPONSE; BRAF INHIBITOR;
D O I
10.1038/s41574-020-0398-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With immune checkpoint blockade (ICB) technologies increasingly being used in cancer immunotherapy, early data suggest that ICB therapies could be effective in thyroid cancer. This Review discusses our current knowledge of the immune response in thyroid cancers, the latest and ongoing immune-based approaches and the future of immunotherapies in thyroid cancer. In the past decade, the field of cancer immunotherapy has been revolutionized by immune checkpoint blockade (ICB) technologies. Success across a broad spectrum of cancers has led to a paradigm shift in therapy for patients with advanced cancer. Early data are now accumulating in progressive thyroid cancers treated with single-agent ICB therapies and combination approaches that incorporate ICB technologies. This Review discusses our current knowledge of the immune response in thyroid cancers, the latest and ongoing immune-based approaches, and the future of immunotherapies in thyroid cancer. Physiologically relevant preclinical mouse models and human correlative research studies will inform development of the next stage of immune-based therapies for patients with advanced thyroid cancer.
引用
收藏
页码:629 / 641
页数:13
相关论文
共 166 条
[21]   Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease [J].
Busaidy, Naifa Lamki ;
Cabanillas, Maria E. .
JOURNAL OF THYROID RESEARCH, 2012, 2012
[22]   The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer - A long-term follow-up study [J].
Caballero Y. ;
López-Tomassetti E.M. ;
Favre J. ;
Santana J.R. ;
Cabrera J.J. ;
Hernández J.R. .
Thyroid Research, 8 (1)
[23]   Tumor-Associated Macrophages (TAMs) Form an Interconnected Cellular Supportive Network in Anaplastic Thyroid Carcinoma [J].
Caillou, Bernard ;
Talbot, Monique ;
Weyemi, Urbain ;
Pioche-Durieu, Catherine ;
Al Ghuzlan, Abir ;
Bidart, Jean Michel ;
Chouaib, Salem ;
Schlumberger, Martin ;
Dupuy, Corinne .
PLOS ONE, 2011, 6 (07)
[24]   The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy [J].
Calabrese, Leonard ;
Mariette, Xavier .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (02) :162-164
[25]   PD-1 Blockade in Anaplastic Thyroid Carcinoma [J].
Capdevila, Jaume ;
Wirth, Lori J. ;
Ernst, Thomas ;
Ponce Aix, Santiago ;
Lin, Chia-Chi ;
Ramlau, Rodryg ;
Butler, Marcus O. ;
Delord, Jean-Pierre ;
Gelderblom, Hans ;
Ascierto, Paolo A. ;
Fasolo, Angelica ;
Fuehrer, Dagmar ;
Huetter-Kroenke, Marie Luise ;
Forde, Patrick M. ;
Wrona, Anna ;
Santoro, Armando ;
Sadow, Peter M. ;
Szpakowski, Sebastian ;
Wu, Hongqian ;
Bostel, Geraldine ;
Faris, Jason ;
Cameron, Scott ;
Varga, Andreea ;
Taylor, Matthew .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (23) :2620-+
[26]   Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes [J].
Carretero, Rafael ;
Wang, Ena ;
Rodriguez, Ana I. ;
Reinboth, Jennifer ;
Ascierto, Maria L. ;
Engle, Alyson M. ;
Liu, Hui ;
Camacho, Francisco M. ;
Marincola, Francesco M. ;
Garrido, Federico ;
Cabrera, Teresa .
INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (02) :387-395
[27]   Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy [J].
Chacon, Jessica Ann ;
Sarnaik, Amod A. ;
Chen, Jie Qing ;
Creasy, Caitlin ;
Kale, Charuta ;
Robinson, John ;
Weber, Jeffrey ;
Hwu, Patrick ;
Pilon-Thomas, Shari ;
Radvanyi, Laszlo .
CLINICAL CANCER RESEARCH, 2015, 21 (03) :611-621
[28]   Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade [J].
Chen, Pei-Ling ;
Roh, Whijae ;
Reuben, Alexandre ;
Cooper, Zachary A. ;
Spencer, Christine N. ;
Prieto, Peter A. ;
Miller, John P. ;
Bassett, Roland L. ;
Gopalakrishnan, Vancheswaran ;
Wani, Khalida ;
De Macedo, Mariana Petaccia ;
Austin-Breneman, Jacob L. ;
Jiang, Hong ;
Chang, Qing ;
Reddy, Sangeetha M. ;
Chen, Wei-Shen ;
Tetzlaff, Michael T. ;
Broaddus, Russell J. ;
Davies, Michael A. ;
Gershenwald, Jeffrey E. ;
Haydu, Lauren ;
Lazar, Alexander J. ;
Patel, Sapna P. ;
Hwu, Patrick ;
Hwu, Wen-Jen ;
Diab, Adi ;
Glitza, Isabella C. ;
Woodman, Scott E. ;
Vence, Luis M. ;
Wistuba, Ignacio I. ;
Amaria, Rodabe N. ;
Kwong, Lawrence N. ;
Prieto, Victor ;
Davis, R. Eric ;
Ma, Wencai ;
Overwijk, Willem W. ;
Sharpe, Arlene H. ;
Hu, Jianhua ;
Futreal, P. Andrew ;
Blando, Jorge ;
Sharma, Padmanee ;
Allison, James P. ;
Chin, Lynda ;
Wargo, Jennifer A. .
CANCER DISCOVERY, 2016, 6 (08) :827-837
[29]   A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer [J].
Chintakuntlawar, Ashish V. ;
Yin, Jun ;
Foote, Robert L. ;
Kasperbauer, Jan L. ;
Rivera, Michael ;
Asmus, Erik ;
Garces, Nina I. ;
Janus, Jeffrey R. ;
Liu, Minetta ;
Ma, Daniel J. ;
Moore, Eric J. ;
Morris, John C., III ;
Neben-Wittich, Michelle ;
Price, Daniel L. ;
Price, Katharine A. ;
Ryder, Mabel ;
Van Abel, Kathryn M. ;
Hilger, Crystal ;
Samb, Eleyna ;
Bible, Keith C. .
THYROID, 2019, 29 (11) :1615-1622
[30]   Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study [J].
Chintakuntlawar, Ashish V. ;
Rumilla, Kandelaria M. ;
Smith, Carin Y. ;
Jenkins, Sarah M. ;
Foote, Robert L. ;
Kasperbauer, Jan L. ;
Morris, John C. ;
Ryder, Mabel ;
Alsidawi, Samer ;
Hilger, Crystal ;
Bible, Keith C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (06) :1943-1950